TrialNeuro-oncology2026

Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.

Antonio Omuro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.